ChemicalBook > Produktkatalog >Analytische Chemie >Standard >Pharmazeutische Referenzstandards und Verunreinigungsreferenzstandards >Dolutegravir Impurity C

Dolutegravir Impurity C

1802141-49-6

CAS-Nr.: 1802141-49-6

Englisch Name:: Dolutegravir Impurity C

Synonyma:: Dolutegravir Impurity 20;Dolutegravir Impurity 23;Dolutegravir Impurity 32;Syringaresinol Impurity 1(Syringaresinol Diglucoside);(4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1,2:;(4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-7-ethoxy-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-, (4R,12aS)-

CBNumber:: CB96222324

Summenformel:: C22H23F2N3O5

Molgewicht:: 447.43

MOL-Datei:: 1802141-49-6.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 9

Dolutegravir Impurity C Eigenschaften

Siedepunkt:: 688.1±55.0 °C(Predicted)

Dichte: 1.42±0.1 g/cm3(Predicted)

pka: 10.71±0.40(Predicted)

Sicherheit

Dolutegravir Impurity C Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

O-Ethyl Dolutegravir is an impurity of Dolutegravir (D528800), which is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.

Dolutegravir Impurity C Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Dolutegravir Impurity C Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Guangzhou Jiuzhi Pharmaceutical Technology Co., Ltd.	020-89854820	sales@jzpharma.cn	China	1050	58
Shenzhen Hengfeng Wanda Pharmaceutical Technology Co., Ltd	0755-22677922 18126518403	2851922760@qq.com	China	5043	58
Molcoo Chemicals Inc.	18627923403 18627753421	3001006472@qq.com	China	8970	58
Shenzhen Roark Pharma-Tec Co., Ltd.	13128912434	2880126944@qq.com	China	2579	58
guoyungurui	18162595016	3287908757@qq.com	China	10012	58
ShenZhen H&D Pharmaceutical Technology Co., LTD	18367470722	2885785763@qq.com	China	3670	58

Dolutegravir Impurity 20
(4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1,2:
Dolutegravir Impurity 23
(4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-7-ethoxy-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-, (4R,12aS)-
Dolutegravir Impurity 32
Syringaresinol Impurity 1(Syringaresinol Diglucoside)
1802141-49-6